Applicant, as named in the Orange Book

Esteve

Next listed expiry: Quzyttir on 28 Feb 2030. 1 products with live protection, 3 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Quzyttir cetirizine hydrochloride	cetirizine hydrochloride	211415	28 Feb 2030	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (3)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lysodren mitotane	mitotane	016885	open now	no listed protection
Metopirone metyrapone	metyrapone	012911	open now	no listed protection
Prialt · 3 strengths ziconotide acetate	ziconotide acetate	021060	open now	no listed protection